Comprehensive Online Oncology Database
New Medicine Oncology KnowledgeBASE
NEWS
SUBSCRIBER SEARCH
(Requires Login)
NEW DRUG
MARKETED DRUG
COMPANY
TARGETS IN ONCOLOGY
NEWS AND WEBCAST SUMMARIES
COMBINATION TRIALS
  
   1-949-830-0448   info@newmedinc.com   
 
ABOUT nm|OK
nm|OK FREE ACCESS AND DEMO
APPLICATIONS
DESCRIPTION OF MODULES
INQUIRIES AND FEEDBACK
LICENSE AGREEMENT
PRIVACY POLICY
SAMPLE QUERY SCREENS
SAMPLE REPORTS & RECORDS
SOURCES
SUBSCRIPTION INFORMATION
USER GUIDE

PRODUCTS AND SERVICES
FUTURE ONCOLOGY
FEATURED IN-DEPTH REPORTS
CUSTOM REPORT REQUEST

NEWS
NEWS SUMMARIES
LATEST nm|OK UPDATES
nm|OK NEWS RELEASES

SITE MAP
Having trouble finding something?
Use our site map.
 

Latest Updates
June 2008 Marketed Drug Updates and Additions

Brand Name
Generic Name
Other Designation
Thalidomid, Thalomid, Thalidomide Pharmion (outside the USA) Thalidomide  
Vidaza Azacitidine (AzaC), 5-azacytidine NSC-102816
Revlimid (formerly Revimid), Lenalidomide-Celgene Europe Lenalidomide CDC501, CDC-501, CDC-5013, CC5013, CC-5013
Fentora (formerly OraVescent Fentanyl) Fentanyl  
Cervarix Human papillomavirus vaccine, AS04 adjuvant-adsorbed MEDI-517, HPV-16/18, VLP-AS04
Erbitux Cetuximab IMC-C225
Emend Aprepitant MK-869, MK 869, MK 0869, L 754030
Gardasil, Silgard (Eastern Europe) Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine  
Zolinza Vorinostat SAHA, L-001079038
Velcade Bortezomib MLN341 (formerly LDP-341, PS-341 & MG-341)
Gleevec (USA, Canada, Israel), Glivec (Europe) Imatinib mesylate STI-571, STI571, formerly CGP-57148B
Noxafil Posaconazole SCH 56592
Fentanyl Buccal Tablets C-II Fentanyl  
  Fentanyl  
Nudoxa Doxorubicin  


HOME   |   NEW MEDICINE   |   SITE MAP

NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE:  1-949-830-0448     FAX:  1-949-830-0887
INFO@NEWMEDINC.COM